WebBivalirudin is intended for intravenous bolus injection and continuous infusion after reconstitution and dilution. Preparation Instructions for Bolus Injection and Continuous … WebSep 15, 2024 · Bivalirudin (bivalirudin injection, powder, lyophilized, for solution) is a direct thrombin inhibitor indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty ( PTCA ); undergoing percutaneous coronary intervention (PCI) with provisional use of glycoprotein IIb/IIIa …
1 INDICATIONS AND USAGE - Food and Drug Administration
WebBivalirudin Injection is an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI). 2 DOSAGE AND ADMINISTRATION . 2.1 Recommended Dosage . The recommended dose of Bivalirudin Injection is an intravenous bolus dose of 0.75 mg/kg, followed immediately by a maintenance infusion of 1.75 mg/kg/h for the … WebA recommended alternative to heparin, bivalirudin, has its own disadvantages, including the lack of a reversal agent. ... Note that activated clotting time values measured in the blood samples collected before dabigatran injection and measured in the several samples collected at 420 min after injection, were below the level of detection (“out ... opal silvertown llp
Bivalirudin (Mylan Institutional LLC): FDA Package Insert
Webbivalirudin for injection - ADD-VANTAGE Quick Finder Pfizer samples (for eligible HCPs) Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426or by visiting the PfizerPro website www.pfizerpro.com. Report an adverse event or concern about the quality of a Pfizer product WebBivalirudin is intended for intravenous bolus injection and continuous infusion after reconstitution and dilution. Preparation Instructions for Bolus Injection and Continuous Infusion. To each 250 mg vial, add 5 mL of Sterile Water for Injection, USP. Gently swirl … WebBivalirudin exhibits linear pharmacokinetics following IV administration to patients undergoing PTCA. In these patients, a mean steady state bivalirudin concentration of 12.3 ± 1.7 mcg/mL is achieved following an IV bolus of 1 mg/kg and a 4-hour 2.5 mg/kg/h IV infusion. Distribution. Bivalirudin does not bind to plasma proteins (other than ... opal silver earrings